image

Boehringer Ingelheim - Company Information

Boehringer Ingelheim is a global pharmaceutical company specializing in prescription medicines, consumer health, and animal health products, as well a...Read more

Biotech & Pharmaceuticals
  • icon
    Headquarters

    Mainz, Rheinland-Pfalz, Germany

  • icon
    Contact

    Unlock contact

  • icon
    Linkedin

    linkedin icon

  • icon
    Company Size

    10,000+

  • icon
    Stock Symbol

    N/A

  • icon
    Website

    boehringer-ingelheim.com

  • icon
    Type

    Private

icon

Boehringer Ingelheim Technology Stack

Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Boehringer Ingelheim

image

SAP S/4HANA Finance

thumbs_up

thumbs_down

SAP S/4HANA Finance provides a deployment model for organisations and helps in performing...

See more technologies

Boehringer Ingelheim Employee Profiles

Are you looking for the decision-makers at Boehringer Ingelheim? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Boehringer Ingelheim’s employee details in less than 30 secs.

Sign-up for 6sense Revenue AI™ for Sales

To find emails, direct dials, and more for prospects across the web.

Sign Up Today

Boehringer Ingelheim Competitors

Discover Boehringer Ingelheim alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.

image

Schweizer Kaffeemaschinen GmbH

  • icon
    Total Employees

    20 - 49

  • icon
    Location

    Dornstetten

  • icon
    Website

    schweizer-kaffeemaschinen.de

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Redivivus Antiquariat

  • icon
    Total Employees

  • icon
    Location

    Regensburg

  • icon
    Website

    redivivus.de

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Ulrike Cusnick - Sander

  • icon
    Total Employees

    10 - 19

  • icon
    Location

    Bad Duerkheim

  • icon
    Website

    taxi-cusnick.de

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Harms & Harms Immobilien GmbH

  • icon
    Total Employees

    0 - 9

  • icon
    Location

    Aurich

  • icon
    Website

    makler24.com

  • icon
    Type

    N/A

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

image

Methodist Healthcare System

  • icon
    Total Employees

    10,000+

  • icon
    Location

    San Antonio

  • icon
    Website

    sahealth.com

  • icon
    Type

    Public

  • icon
    Stock Symbol

    N/A

  • icon
    Linkedin

    linkedin icon

Download the 6sense Chrome Extension to get verified contact data of Boehringer Ingelheim employees

Install Now
Company Logo

Boehringer Ingelheim News & Press Releases

Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Boehringer Ingelheim latest news, alerts and updates.

Boehringer Ingelheim appoints new board members

Boehringer Ingelheim announces key appointments to its board of managing directors: Michael Schmelmer is appointed vice chairman effective May 1, 2024, retaining responsibility for Group Functions. He joined in 2012, was appointed to the board in 2018, and added to group functions in 2019.

Date Icon

27 Dec 2023

Boehringer Ingelheim to acquire T3 Pharmaceuticals in deal worth over $500m

Boehringer Ingelheim has said it will be acquiring bacterial cancer therapy specialist T3 Pharmaceuticals in a deal worth over $500m, marking a significant boost to its immuno-oncology portfolio. The U.

Date Icon

24 Nov 2023

Boehringer Ingelheim to acquire T3 Pharmaceuticals in deal worth over $500m

Boehringer Ingelheim has said it will be acquiring bacterial cancer therapy specialist T3 Pharmaceuticals in a deal worth over $500m, marking a significant boost to its immuno-oncology portfolio. Boehringer said it is seeking to “significantly increase” the current 15 to 20% remission rate in cancer patients by utilising complementary immuno-oncology platforms such as T-cell engagers,

Date Icon

23 Nov 2023

FAQs for Boehringer Ingelheim

Explore frequently asked questions about Boehringer Ingelheim’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.

What is Boehringer Ingelheim's official website?

The official website of Boehringer Ingelheim is boehringer-ingelheim.com You can find their contact number, email address, and headquarters by clicking here.

faq icon

How many employees are working at Boehringer Ingelheim?

faq icon

What industry is Boehringer Ingelheim in?

faq icon

What is Boehringer Ingelheim's tech stack?

faq icon

Where are Boehringer Ingelheim's headquarters?

faq icon

Get instant access to B2B contact data across the web

Sign Up Today
6sense Logo
social iconssocial iconssocial iconssocial icons
MarketingAccount IdentificationIntent DataData Enrichment & ManagementPredictive AnalyticsOrchestrations & WorkflowsAudience BuildingAdvertisingConversational EmailPipeline IntelligenceIntegrations
SolutionsBusiness ServicesFinancial ServicesTransportation & LogisticsManufacturingTechnologyCustomersMeet Our CustomersCustomer StoriesCustomer ReviewsRevCityKnowledge Base

Company

AboutLeadership TeamCareersNewsroomCommunity

Browse 6sense Data

TechnographicsComparing TechnologiesCompany SearchPeople Search
TermsPrivacy PolicyPrivacy CenterDo Not Sell or Share My Personal Information

© 2024 6sense